Detection, Quantification, and Characterisation of HIV/SIV

Methods in Molecular Biology

Volumn 665, Issue , 2011, Pages 133-160

  Berry, Neil ^a   Herrera, Carolina ^b   Cranage, Martin ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Colorectal explant cultures; HIV; Infectivity assay; Nucleic acid testing; PCR; qPCR; SIV

Indexed keywords

ANIMAL; ARTICLE; COMPARATIVE STUDY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; HIV; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79955853869     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-817-1_9     Document Type: Chapter

References (21)

1. Schuitemaker, H. and Kootstra, N.A. (2005) Determination of co-receptor usage of HIV-1. In: Human Retrovirus Protocols: Virology and Molecular Biology; Methods in Molecular Biology 304:327–332.
2. Greenhead, P., Hayes, P., Watts, P.S., Laing, K.G., Griffin, G.E., and Shattock, R.J. (2000) Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 74, 5577–5586.
3. Abner, S.R., Guenthner, P.C., Guarner, J., Hancock, K.A., Cummins, J.E. Jr., Fink, A., et al. (2005) A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis 192, 1545–1556.
4. McCutchan, F.E. (2006) Global epidemiology of HIV. J Med Virol 78, S7–S12.
5. Hu, S.-L. (2005) Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 5, 193–201.
6. Platt, E.J., Wehrly, K., Kuhmann, S.E., Chesebro, B., and Kabat, D. (1998) Effects of CCR5 and CD4 cell surface concentrations on infection by macrophage tropic isolates of human immunodeficiency virus type 1. J Virol 72, 2855–2864.
7. Wei, X., Decker, J.M., Liu, H., Zhang, Z., Arani, R.B., Kilby, J.M., et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46, 1896–1905.
8. Fletcher, P.S., Elliot, J., Grivel, J.C., Margolis, L., Anton, P., McGowan, I., et al. (2006) Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS 20, 1237–1245.
9. Hladik, F., Sakchalathorn, P., Ballweber, L., Lentz, G., Fialkow, M., Eschenbach, D., et al. (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26, 257–270.
10. Cranage, M., Sharpe, S., Herrera, C., Cope, A., Dennis, M., Berry, N., et al. (2008) Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med 5, e157.
11. Berry, N.J., Ariyoshi, K., Jaffar, S., Sabally, S., Corrah, T., Tedder, R., et al. (1998) Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol 1, 457–468.
12. Berry, N., Davis, C., Jenkins, A., Wood, D., Minor, P., Schild, G., et al. (2001) Vaccine safety: analysis of oral polio vaccine CHAT stocks. Nature 410, 1046–1047.
13. Berry, N., Jenkins, A., Martin, J., Davis, C., Wood, D., Schild, G., et al. (2005) Mitochondrial DNA and retroviral RNA analyses of archival oral poliovirus materials: evidence of macaque nuclear sequences confirms substrate identity. Vaccine 23, 1639–1648.
14. Berry, N.J., Jaffar, S., Schim van der Loeff, M., Ariyoshi, K., Harding, E., N’Gom, P., Dias, F., Wilkins, A., Ricard, D., Aaby, P., Tedder, R., and Whittle, H. (2002) Low level viraemia and high CD4% predict normal survival of a cohort of HIV-2-infected villagers. AIDS Res Hum Retro 18, 1167–1173.
15. Berry, N., Stebbings, R., Ferguson, D., Ham, C., Alden, J., Brown, S., Jenkins, A., et al. (2008) Resistance to superinfection of a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J Gen Virol 89, 2240–2251.
16. Keele, B.F., Giorgi, E.E., Salazar-Gonzalez, J.F., Decker, J.M., Pham, K.T., Salazar, M.G., et al. (2008) Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 105, 7552–7557.
17. Salazar-Gonzalez, J.F., Bailes, E., Pham, K.T., Salazar, M.G., Guffey, M.B., Keele, B.F., et al. (2008) Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 82, 3952–3970.
18. Simmonds, P., Balfe, P., Peutherer, J., Ludlam, C., Bishop, J., and Leigh-Brown, A. (1990) Human-immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 64, 864–872.
19. Higuichi, R. and Kwok, S. (1989) Avoiding false-positives with PCR. Nature 339, 237.
20. Ehrlich, H.A. Ed. (1989) PCR Technology: Principles and Applications for DNA Amplification. Stockton Press, New York.
21. Clarke, S., Almond, N., and Berry, N. (2003) Simian immunodeficiency virus nef gene regulates the production of 2-LTR circles in vivo. Virology 306, 100–108.